assessing the role of darolutamide in crpc
Published 5 years ago • 238 plays • Length 2:02Download video MP4
Download video MP3
Similar videos
-
2:11
dr. lee on the role of darolutamide in m0crpc
-
1:46
examining the impact of darolutamide on pain and qol in patients with nonmetastatic crpc
-
2:38
safety outcomes of darolutamide vs apalutamide and enzalutamide in nmcrpc
-
2:58
achieving mfs and improved quality of life in nmcrpc with darolutamide
-
0:54
the addition of darolutamide to adt reduces risk of metastasis in nonmetastatic crpc
-
2:14
dr. tagawa discusses darolutamide in crpc
-
1:47
dr. fizazi discusses updated data with darolutamide in crpc
-
![ca prostate [metastatic] - clinics for pg updates- urology season 5-[2024]](https://i.ytimg.com/vi/hcji5XSldzs/mqdefault.jpg)
1:58:56
ca prostate [metastatic] - clinics for pg updates- urology season 5-[2024]
-
6:12
video 23 - cancer recurrence - my prostate cancer story
-
1:03:36
treatments for advanced prostate cancer
-
5:12
darolutamide for nmcrpc: results of the aramis trial
-
2:45
interaction of darolutamide with substrates of cyps and p-gp
-
4:41
darolutamide’s role in treating nonmetastatic crpc
-
1:35
darolutamide and survival in nonmetastatic, castration-resistant prostate cancer
-
2:00
dr. shore on the tolerability of darolutamide in nonmetastatic crpc
-
6:51
understanding nonmetastatic crpc: an overview
-
3:38
the nccn and aua guidelines for treating nmcrpc
-
1:57
aramis: efficacy and safety of darolutamide in nmcrpc
-
3:28
apalutamide and the titan clinical trial
-
8:30
ar-targeted therapies in crpc
-
4:44
aramis: safety and efficacy of darolutamide in nmcrpc
-
1:27
dr. scholz on significance of aramis trial in crpc